Spanish clinical practice consensus in internal medicine on chronic obstructive pulmonary disease patients with comorbidities (miEPOC)

References

• Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985.
   PubMed Web of Science ®Google Scholar
• Llordés M, Jaén A, Almagro P, et al. Prevalence, risk factors and diagnostic accuracy of COPD among smokers in primary care. COPD. 2015;12(4):404–412.
   PubMedGoogle Scholar
• Murray CJ, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–2191.
   PubMed Web of Science ®Google Scholar
• Roversi S, Fabbri LM, Sin DD, et al. Chronic obstructive pulmonary disease and cardiac diseases an urgent need for integrated care. Am J Respir Crit Care Med. 2016;194(11):1319–1336.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurst JR, Suissa S. Cardiovascular disease and COPD: dangerous liaisons. Eur Respir Rev. 2018;27(149):180057.
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Ruiz-Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: A joinpoint regression analysis. Lancet Respir Med. 2014;2(1):54–62.
   PubMed Web of Science ®Google Scholar
• Almagro P, Salvadó M, Garcia-Vidal C, et al. Recent improvement in long-term survival after a COPD hospitalisation. Thorax. 2010;65(4):298–302.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017. Pharmacological treatment of stable phase. Arch Bronconeumol. 2017;53(6):324–335.
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report: GOLD Executive Summary. Eur Respir J. 2017;49(3):1700214.
   PubMed Web of Science ®Google Scholar
• Westerik JAM, Metting EI, van Boven JFM, et al. Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir Res. 2017;18(1):31.
   PubMedGoogle Scholar
• Lopez-Campos JL, Hartl S, Pozo-Rodriguez F, et al. Variability of hospital resources for acute care of COPD patients: the European COPD Audit. Eur Respir J. 2014;43(3):754–762.
   PubMed Web of Science ®Google Scholar
• Price LC, Lowe D, Hosker HSR, et al. UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax. 2006;61(10):837–842.
   PubMed Web of Science ®Google Scholar
• Escarrabill J, Torrente E, Esquinas C, et al. Auditoría clínica de los pacientes que ingresan en el hospital por agudización de EPOC. Estudio MAG-1. Arch Bronconeumol. 2015;51(10):483–489.
   PubMedGoogle Scholar
• Vanfleteren LE. Does COPD stand for “COmorbidity with Pulmonary Disease”? Eur Respir J. 2015;45(1):14–17.
   PubMed Web of Science ®Google Scholar
• Almagro P, Ponce A, Komal S, et al. Multimorbidity gender patterns in hospitalized elderly patients. Plos One. 2020;15:e0227252. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Hughes LD, McMurdo ME, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2013;42(1):62–69.
   PubMed Web of Science ®Google Scholar
• Förster B, von der Gracht H. Assessing Delphi panel composition for strategic foresight – a comparison of panels based on company – internal and external participants. Technol Forecast Soc Change. 2014;84:215–229.
   Web of Science ®Google Scholar
• de Meyrick J. The Delphi method and health research. Health Educ. 2003;103(1):7–16.
   Google Scholar
• Hussler C, Muller P, Rond P. Is diversity in Delphi panelist groups useful? Evidence from a French forecasting exercise on the future of nuclear energy. Technol Forecast Soc Change. 2011;78(9):1642–1653.
   Web of Science ®Google Scholar
• Boulkedid R, Abdoul H, Loustau M, et al. Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLOS One. 2011;6(6):e20476.
   PubMed Web of Science ®Google Scholar
• Diamond IR, Grant RC, Feldman BM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67(4):401–409.
   PubMed Web of Science ®Google Scholar
• von der Gracht HA. Consensus measurement in Delphi studies. Review and implications for future quality assurance. Technol Forecast Soc Change. 2012;79(8):1525–1536.
   Web of Science ®Google Scholar
• Hsu CC, Sandford B. The Delphi technique: making sense of consensus. Pract Assessment Res Eval. 2007;12:1–8.
   Google Scholar
• Almagro P, Lapuente A, Pareja J, et al. Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study. Int J Chron Obstruct Pulmon Dis. 2015;16(10):1353–1361.
   Google Scholar
• Almagro P, De la Sierra A, Acosta E, et al. Spirometrically confirmed chronic obstructive pulmonary disease worsens long-term prognosis after percutaneous coronary intervention. Am J Respir Crit Care Med. 2018;197(6):824–826.
   PubMed Web of Science ®Google Scholar
• Almagro P, Cabrera FJ, Diez J, et al. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en servicios de medicina interna (ESMI) study. Chest. 2012;142(5):1126–1133.
   PubMed Web of Science ®Google Scholar
• Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Proceso Asistencial Integrado Del Paciente Con EPOC Exacerbado (PACEX-EPOC). Editorial RESPIRA-Fundación Española del pulmón-SEPAR; 2015.
   Google Scholar
• Pellicer Císcar C, Soler Cataluña JJ, Andreu Rodríguez AL, et al. Diagnosis of COPD in hospitalised patients. Arch Bronconeumol. 2010;46(2):64–69.
   PubMed Web of Science ®Google Scholar
• Fisk M, McMillan V, Brown J, et al. Inaccurate diagnosis of COPD: the Welsh National COPD audit. Br J Gen Pract. 2019;69(678):e1–e7.
   PubMed Web of Science ®Google Scholar
• Bhatt NY, Wood KL. What defines abnormal lung function in older adults with chronic obstructive pulmonary disease? Drugs Aging. 2008;25(9):717–728.
   PubMed Web of Science ®Google Scholar
• Allen S, Yeung P, Janczewski M, et al. Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment. Clin Respir J. 2008;2(4):208–213.
   PubMed Web of Science ®Google Scholar
• Represas-Represas C, Fernández-Villar A, Ruano-Raviña A, et al. Screening for chronic obstructive pulmonary disease: validity and reliability of a portable device in non-specialized healthcare settings. PLoS One. 2016;11(1):e0145571.
   PubMed Web of Science ®Google Scholar
• Lorenzo Hernández MV, Yun S, Acosta E, et al. Usefulness of the FEV1/FEV6 ratio to detect the prevalence of lung obstruction in hospitalised patients with multiple morbidities. Rev Esp Geriatr Gerontol. 2017;52(4):119–193.
   PubMedGoogle Scholar
• Komal S, Simon L, Grau G, et al. Utility of FEV1/FEV6 index in patients with multimorbidity hospitalized for decompensation of chronic diseases. PLOS One. 2019;14(8):e0220491.
   PubMed Web of Science ®Google Scholar
• Ni Y, Shi G, Yu Y, et al. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:1465–1475.
   PubMed Web of Science ®Google Scholar
• García-Vidal C, Almagro P, Romaní V, et al. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Eur Respir J. 2009;34(5):1072–1078.
   PubMed Web of Science ®Google Scholar
• Kim KH, Kang HS, Kim JS, et al. Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease. COPD. 2017;12:3449–3456.
   Google Scholar
• Kiff C, Ruiz S, Varol N, et al. Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy versus triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK. COPD. 2018;13:2707–2720.
   Google Scholar
• Joo H, Han D, Lee JH, et al. Incidence of adverse effects and discontinuation rate between patients receiving 250 micrograms and 500 micrograms of roflumilast: a comparative study. Tuberc Respir Dis. 2018;81(4):299–304.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–1276.
   PubMedGoogle Scholar
• Jouneau S, Dres M, Guerder A, et al. Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de pneumologie de langue française (summary). Rev Mal Respir. 2017;34(4):282–322.
   PubMed Web of Science ®Google Scholar
• Walters JA, Tan DJ, White CJ, et al. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;3:CD006897.
   Google Scholar
• Pozo-Rodríguez F, López-Campos JL, Alvarez-Martínez CJ, et al. Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study. PLOS One. 2012;7(7):e42156.
   PubMed Web of Science ®Google Scholar
• Rueda-Camino JA, Bernal-Bello D, Canora-Lebrato J, et al. High doses of systemic corticosteroids in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. A cohort study. Rev Clin Esp. 2017;217(9):504–509.
   PubMed Web of Science ®Google Scholar
• Marcos PJ, Nieto-Codesido I, de Jorge Dominguez-Pazos S, et al. Treatment with systemic steroids in severe chronic obstructive pulmonary disease exacerbations: use of short regimens in routine clinical practice and their impact on hospital stay. Arch Bronconeumol. 2017;53(11):611–615.
   PubMed Web of Science ®Google Scholar